{"date":"2026-07-24","count":18,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-4116-2026-07-24-1952-14tjiop","company_id":"4116","company":"明基醫","market":"上櫃","industry":"生技醫療","date":"2026-07-24","time":"19:52:57","subject":"民國115年第二季財務報告董事會預計召開日期為民國115年08月03日","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：明基醫（4116），2026-07-24 19:52，「民國115年第二季財務報告董事會預計召開日期為民國115年08月03日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7762-2026-07-24-1855-1xrfgxy","company_id":"7762","company":"吉晟生","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"18:55:19","subject":"公告本公司114年度第一次員工認股權憑證認股價格調整","clause":"第44款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：吉晟生（7762），2026-07-24 18:55，「公告本公司114年度第一次員工認股權憑證認股價格調整」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6919-2026-07-24-1813-lcov0i","company_id":"6919","company":"康霈*","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"18:13:36","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月3日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：康霈*（6919），2026-07-24 18:13，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年8月3日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-07-24-1747-1aq7iqo","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"17:47:39","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-07-31","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-07-24 17:47，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2026-07-24-1736-1aq7iqo","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"17:36:46","subject":"本公司受邀參加元大證券舉辦之法人說明會","clause":"第30款","fact_date":"2026-07-30","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2026-07-24 17:36，「本公司受邀參加元大證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7837-2026-07-24-1632-5k3h8e","company_id":"7837","company":"啟新生","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"16:32:38","subject":"代重要子公司台美檢驗科技股份有限公司公告現金股利除息基準日","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：啟新生（7837），2026-07-24 16:32，「代重要子公司台美檢驗科技股份有限公司公告現金股利除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-24-1617-tvo5ko","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"16:17:57","subject":"公告本公司總經理異動(新任生效日期更正)","clause":"第6款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-24 16:17，「公告本公司總經理異動(新任生效日期更正)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7776-2026-07-24-1557-13b4j9p","company_id":"7776","company":"奧孟亞","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"15:57:40","subject":"公告本公司取得經濟部產業發展署出具「係屬科技事業及產品開發成功且具市場性」之意見書","clause":"第44款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：奧孟亞（7776），2026-07-24 15:57，「公告本公司取得經濟部產業發展署出具「係屬科技事業及產品開發成功且具市場性」之意見書」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-24-1511-1m9h75b","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"15:11:09","subject":"公告本公司聘任新任財務主管、公司治理主管","clause":"第8款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-24 15:11，「公告本公司聘任新任財務主管、公司治理主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-24-1510-wr0tu2","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"15:10:18","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-24 15:10，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-24-1509-11wjw0o","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"15:09:21","subject":"公告本公司董事會決議股利分派","clause":"第14款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-24 15:09，「公告本公司董事會決議股利分派」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6534-2026-07-24-1508-37n2dy","company_id":"6534","company":"正瀚-創","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"15:08:19","subject":"公告本公司董事會通過115年第二季合併財務報告","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：正瀚-創（6534），2026-07-24 15:08，「公告本公司董事會通過115年第二季合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-3705-2026-07-24-1454-vpi6gh","company_id":"3705","company":"永信","market":"上市","industry":"生技醫療","date":"2026-07-24","time":"14:54:09","subject":"代子公司CARLSBAD TECHNOLOGY, INC.公告董事會決議召開2026年股東會(變更股東會日期)","clause":"第17款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：永信（3705），2026-07-24 14:54，「代子公司CARLSBAD TECHNOLOGY, INC.公告董事會決議召開2026年股東會(變更股東會日期)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7814-2026-07-24-1427-18bhctm","company_id":"7814","company":"海昌生技","market":"上櫃","industry":"生技醫療","date":"2026-07-24","time":"14:27:21","subject":"公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果","clause":"第53款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：海昌生技（7814），2026-07-24 14:27，「公告本公司初次上櫃掛牌首五個營業日穩定價格操作結果」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6543-2026-07-24-1409-193bb66","company_id":"6543","company":"普惠醫工","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"14:09:28","subject":"公告本公司調整盈餘轉增資之配股率","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：普惠醫工（6543），2026-07-24 14:09，「公告本公司調整盈餘轉增資之配股率」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6242-2026-07-24-1352-58p4oj","company_id":"6242","company":"立康","market":"上櫃","industry":"生技醫療","date":"2026-07-24","time":"13:52:22","subject":"公告本公司115年第2季合併財務報告董事會召開日期","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：立康（6242），2026-07-24 13:52，「公告本公司115年第2季合併財務報告董事會召開日期」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7561-2026-07-24-0936-x7myh7","company_id":"7561","company":"光晟生技","market":"興櫃","industry":"生技醫療","date":"2026-07-24","time":"09:36:51","subject":"公告本公司董事會通過第一屆永續發展委員會委員(更正7/13重訊)","clause":"第6款","fact_date":"2026-07-13","cite_as":"公開資訊觀測站重大訊息：光晟生技（7561），2026-07-24 09:36，「公告本公司董事會通過第一屆永續發展委員會委員(更正7/13重訊)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6527-2026-07-24-0832-fzkg7m","company_id":"6527","company":"明達醫","market":"上櫃","industry":"生技醫療","date":"2026-07-24","time":"08:32:02","subject":"公告本公司115年第二季合併財務報告董事會預計召開日期為115年08月03日","clause":"第31款","fact_date":"2026-07-24","cite_as":"公開資訊觀測站重大訊息：明達醫（6527），2026-07-24 08:32，「公告本公司115年第二季合併財務報告董事會預計召開日期為115年08月03日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}